BIT
Click for more information
0.00% 3.4¢ biotron limited

Ann: BIT225 Phase 2 HIV Efficacy Trial Meets Primary Objectives, page-107

  1. NZ Trader
    11,863 Posts.
    lightbulb Created with Sketch. 6015
    clock Created with Sketch.
    20/06/24
    09:13
    Post #: 74402564
    100% agree ,,,

    Full Data Read Out Required .... Phase II Primary End Points Achieved ,,,, the opposite side of the coin ,, Phase II Failure would see a 1c stock at best..
    Company needs to gain further Editorial to push the news ,,, ASX Announcements are the bare minimum ASX Regulatory Requirement..

    Looking forward to greater market awareness in the future NZT
    BIT Price at posting: 4.8¢ Sentiment: Buy Disclosure: Held
    Likes Created with Sketch. 3  Upvote
    lightbulb Created with Sketch.  Great analysis
    Stroke 3 Created with Sketch. Comments Created with Sketch. Reply

  2. Top Stories

 

Featured News

GNX NSW approves J-POWER's $380M buyout of Genex Power, giving it ownership of QLD net zero project
right-arrow Created with Sketch.
AUN Aurumin reports high-grade iron ore rock chips at Central Sandstone, WA
right-arrow Created with Sketch.
EVN Evolution shares up 3% on quarterly results for June showing rise in gold production
right-arrow Created with Sketch.
ABY Adore Beauty FY24 revenues up 7.4% YoY to $196M
right-arrow Created with Sketch.
FMG Andrew Forrest was seemingly possessed by the spirit of hydrogen – now he's cut 700 jobs and canned FFI
right-arrow Created with Sketch.
NEWS Talking Australia's very competitive property landscape: Realty Talks
right-arrow Created with Sketch.
watchlist Created with Sketch. Add BIT (ASX) to my watchlist
(20min delay)
Last
3.4¢ 		Change
0.000(0.00%) 		Mkt cap ! $30.67M
Open High Low Value Volume
3.3¢ 3.5¢ 3.3¢ $12.66K 367.6K

Buyers (Bids)

No. Vol. Price($)
1 155931 3.4¢
 

Sellers (Offers)

Price($) Vol. No.
3.6¢ 113208 2
View Market Depth
Last trade - 16.10pm 22/07/2024 (20 minute delay) ?
BIT (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.